REVIVE: targeted therapy for uncontrolled erythrocytosis in PV with rusfertide
4 months ago
[{"url":"https://i.ytimg.com/vi/YPkMU6CTlXY/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCK5vCqkrCyUJKdLEtVJLdrhgmN2A","width":360,"height":202},{"url":"https://i.ytimg.com/vi/YPkMU6CTlXY/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLAVQHZ889vVQD08CjDOPF8C4NGi0Q","width":720,"height":404}]
[{"text":"Elevated hematocrit is a hallmark of polycythemia vera (PV), and it is associated with higher rates of death. Whilst it is essential to\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"REVIVE: targeted therapy for uncontrolled erythrocytosis in PV with rusfertide by VJHemOnc \u2013 Video Journal of Hematological Oncology 111 views 4 months ago 9 minutes, 7 seconds","duration":"9 minutes, 7 seconds"}